Skip to content

Comparison of regional anaesthesia technique for reconstructive breast surgery

Comparison of bilevel ESP block with opioid based general anesthesia (fentanyl PCA) in pedicle graft - based breast reconstruction utilising LD flap - BiESP

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048141
Enrollment
60
Registered
2022-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C506- Malignant neoplasm of axillary tail of breast Health Condition 2: C509- Malignant neoplasm of breast of unspecified site Health Condition 3: C501- Malignant neoplasm of central portion of breast Health Condition 4: C503- Malignant neoplasm of lower-innerquadrant of breast Health Condition 5: C505- Malignant neoplasm of lower-outerquadrant of breast Health Condition 6: C500- Malignant neoplasm of nipple and areola Health Condition 7: C508- Malignant neoplasm of overlappi

Interventions

Intervention1: Bilevel erector spinae block: Bilevel erector spinae block in breast reconstruction involving latissimus dorsi pedicle flap. 20 ml of rpoivacaine 0.25% with a dose limit not exceeding 2

Sponsors

Pooja VM HCG Hospital Bangalore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient undergoing reconstructive breast surgery belonging to American Society of Anesthesiologists (ASA) physical status 1- 3

Exclusion criteria

Exclusion criteria: 1)Patients not willing to be a part of the study. 2)Patients allergic to local anaesthetic drug. 3)Patients with infection in the area of planned injection site. 4)Patients with cognitive dysfunction, dementia, preexisting communication disorders 5) Emergency surgeries. 6) Patients currently prescribed with ongoing preoperative opioid analgesics or who had current acute pain being treated or chronic pain syndromes or those receiving medical therapies considered to result in tolerance to opioid, deranged organ system function in the form of altered coagulation profile, severe hepatic and renal dysfunction.

Design outcomes

Primary

MeasureTime frame
Pain score evaluation among the groups.Timepoint: Immediate post operative period till hospital discharge

Secondary

MeasureTime frame
Quality of recovery patient satisfaction and opioid consumptionTimepoint: Immediate post operative period till hospital discharge

Countries

India

Contacts

Public ContactPOOJA V M

HCG Hospital

gowda.pooja403@gmail.com8553154341

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026